EUS-guided FNA of centrally located lung tumours following a non-diagnostic bronchoscopy.

OBJECTIVE To assess the feasibility and yield of endoscopic ultrasound (EUS) guided fine needle aspiration (FNA) in diagnosing centrally located lung tumours after a previously non-diagnostic bronchoscopy. BACKGROUND AND HYPOTHESIS Bronchoscopy fails to establish a diagnosis in up to 30% of patients with suspected lung cancer. Intrapulmonary tumours located near or adjacent to the esophagus might be visualized and biopsied under real-time ultrasound guidance by EUS-FNA. DESIGN Patients with suspected lung cancer and an intrapulmonary tumour located near or adjacent to the esophagus who had undergone a non-diagnostic bronchoscopy, underwent EUS-FNA for diagnostic purposes. Surgical-pathological verification occurred when EUS-FNA was non-diagnostic and in those patients diagnosed with non-small-cell lung cancer by EUS-FNA who were surgical candidates. RESULTS EUS-FNA diagnosed lung cancer in 31 of 32 patients (97%). No complications occurred. The diagnosis obtained by EUS-FNA was confirmed in all 11 patients who were operated. In one case, in which EUS-FNA was non-diagnostic, a lymphoma was diagnosed after pneumonectomy. CONCLUSIONS AND SIGNIFICANCE EUS-FNA qualifies as the next diagnostic step in patients with suspected lung cancer and a non-diagnostic bronchoscopy if the intrapulmonary mass is located adjacent or near the esophagus. In these cases, EUS-FNA may replace computed tomography of the chest (CT)-guided biopsies and reduce the number of exploratory thoracotomies.

[1]  K. Rabe,et al.  Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA. , 2004, Lung cancer.

[2]  A. Fritscher-Ravens.  Endoscopic ultrasound evaluation in the diagnosis and staging of lung cancer. , 2003, Lung cancer.

[3]  R. Yung.  Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy. , 2003, Respiratory care clinics of North America.

[4]  A. M. Salazar,et al.  The role of transthoracic needle biopsy for the diagnosis and staging of lung cancer. , 1993, Clinics in Chest Medicine.

[5]  M. Wiersema,et al.  Evaluation of mediastinal lymphadenopathy with endoscopic US-guided fine-needle aspiration biopsy. , 2001, Radiology.

[6]  Douglas C McCrory,et al.  Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. , 2003, Chest.

[7]  R. Matthay,et al.  The role of bronchoscopy in lung cancer. , 1993, Clinics in chest medicine.

[8]  F. Martinez,et al.  Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. , 1996, Radiology.

[9]  Douglas C McCrory,et al.  Invasive staging of non-small cell lung cancer: a review of the current evidence. , 2003, Chest.

[10]  S. Varadarajulu,et al.  Accuracy of EUS in staging of T4 lung cancer. , 2004, Gastrointestinal endoscopy.

[11]  S. Varadarajulu,et al.  EUS-guided FNA of lung masses adjacent to or abutting the esophagus after unrevealing CT-guided biopsy or bronchoscopy. , 2004, Gastrointestinal endoscopy.

[12]  Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients , 2000 .